Patricia Fitzgerald-Bocarsly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Patricia Fitzgerald-Bocarsly has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Sukhwinder Singh
Department of Pathology, Immunology, and Laboratory Medicine, Rutgers-New Jersey Medical School
7 shared publicationsElizabeth Akbulut
Rutgers School of Graduate Studies, Rutgers Biomedical and Health Sciences, Rutgers University
5 shared publications- Harry J. Hurley
Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School , Newark, NJ
4 shared publications - Utz Herbig
Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers-New Jersey Medical School, Center for Cell Signaling
4 shared publications - Evelyne Kalyoussef
Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A.
3 shared publications Hannah K. Dewald
Rutgers-New Jersey Medical School, Department of Pathology, Immunology, and Laboratory Medicine, 185 South Orange Avenue, Newark, NJ, USA
3 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (45)
Senescent CD8 T effector memory cells are functionally impaired, enriched in aging and disease, and a barrier to immunotherapy
Senescent cells play important roles in various biological processes that promote fitness and health; however, their timely elimination by immune cells is critical to maintain tissue homeostasis and prevent disease. Despite this, senescent cells accumulate systemically with age, suggesting that certain immune cells also become senescent and dysfunctional during aging. In support of this, we previously demonstrated that CD8 T cells, immune cells capable of targeting senescent cells, increasingly develop characteristics of senescence with advancing age in humans. Here, we characterized the senescence state of human SA-βGal-expressing (SA-βGal high ) CD8 T effector memory (EM) cells, their functional capabilities, and their enrichment in aging and disease. Single-cell RNA sequencing revealed that SA-βGal high CD8 T cells with unique transcriptional signatures develop in all stages of T cell differentiation, including in CD8 T EM cells, which increased in abundance with human aging. SA-βGal high CD8 T EM cells expressed various classical markers of senescence and were significantly impaired in their ability to proliferate, produce cytokines, and eliminate senescent human stromal cells. Gene signatures of senescent SA-βGal high CD8 T EM cells were enriched in CD8 T cells from older human donors, patients with age-related disorders, cancer, and in smokers. Furthermore, we show that T cell senescence is distinct from and dominant over T cell exhaustion, limiting the response of CD8 T EM cells to immune checkpoint blockade. Collectively, our study demonstrates that senescence impairs CD8 T EM cell function and reveals the involvement of senescent and dysfunctional CD8 T EM cells in aging, disease, smoking, and responses to immunotherapy.
- 3 November 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (45)
Open AccessSenescent CD8 T effector memory cells are functionally impaired, enriched in aging and disease, and a barrier to immunotherapy
Senescent cells play important roles in various biological processes that promote fitness and health; however, their timely elimination by immune cells is critical to maintain tissue homeostasis and prevent disease. Despite this, senescent cells accumulate systemically with age, suggesting that certain immune cells also become senescent and dysfunctional during aging. In support of this, we previously demonstrated that CD8 T cells, immune cells capable of targeting senescent cells, increasingly develop characteristics of senescence with advancing age in humans. Here, we characterized the senescence state of human SA-βGal-expressing (SA-βGal high ) CD8 T effector memory (EM) cells, their functional capabilities, and their enrichment in aging and disease. Single-cell RNA sequencing revealed that SA-βGal high CD8 T cells with unique transcriptional signatures develop in all stages of T cell differentiation, including in CD8 T EM cells, which increased in abundance with human aging. SA-βGal high CD8 T EM cells expressed various classical markers of senescence and were significantly impaired in their ability to proliferate, produce cytokines, and eliminate senescent human stromal cells. Gene signatures of senescent SA-βGal high CD8 T EM cells were enriched in CD8 T cells from older human donors, patients with age-related disorders, cancer, and in smokers. Furthermore, we show that T cell senescence is distinct from and dominant over T cell exhaustion, limiting the response of CD8 T EM cells to immune checkpoint blockade. Collectively, our study demonstrates that senescence impairs CD8 T EM cell function and reveals the involvement of senescent and dysfunctional CD8 T EM cells in aging, disease, smoking, and responses to immunotherapy.
- Open Access
- 26 October 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1985303
SA-β-Gal stratification reveals senescence-associated heterogeneity and differential cell death susceptibility in human CD8 effector T cells
Introduction: Cellular senescence in human T cells remains incompletely defined, particularly with respect to how senescence-associated states influence susceptibility to cell death. Methods: We used flow-cytometric SPiDER-based detection of senescence-associated β-galactosidase (SA-β-Gal) activity to profile human CD8+ T-cell subsets from young and old donors. We stratified effector memory (CD8 EM ) and effector memory re-expressing CD45RA (CD8 EMRA ) subsets by the lowest (bottom 25%) and highest (top 25%) quartiles of SA-β-Gal signal. Results: CD8 EM and CD8 EMRA cells displayed the greatest within-subset heterogeneity in SA-β-Gal activity. The SA-β-Gal low and high populations occupied distinct regions in UMAP projections and were reproducibly enriched in different FlowSOM metaclusters, indicating that SA-β-Gal activity captures structured phenotypic states within differentiated CD8+ T-cell compartments. These states differed in senescence-associated markers, including CD27, CD28, CD57, and CX3CR1, as well as granzyme-associated programs involving Gzm A, B and K, whereas chronological age had only a limited effect once subsets were analyzed separately. Functionally, nutrient-limited conditions unmasked marked differences in cell death susceptibility between these populations. Following PMA/ionomycin stimulation, SA-β-Gal high CD8 EM and CD8 EMRA cells underwent accelerated stimulation-induced cell death, showed increased caspase-3/7 activation, and exhibited lower post-treatment γH2AX signal relative to SA-β-Gal low counterparts. In contrast, in the absence of stimulation-induced energetic demand, SA-β-Gal high cells displayed greater resistance to cell death. Discussion: Together, SA-β-Gal stratification resolves structured heterogeneity within human CD8 effector T cells and supports a context-dependent model in which senescence-associated effector states become selectively vulnerable to stimulation-induced death under metabolic stress.
- 26 October 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1985303
Open AccessSA-β-Gal stratification reveals senescence-associated heterogeneity and differential cell death susceptibility in human CD8 effector T cells
Introduction: Cellular senescence in human T cells remains incompletely defined, particularly with respect to how senescence-associated states influence susceptibility to cell death. Methods: We used flow-cytometric SPiDER-based detection of senescence-associated β-galactosidase (SA-β-Gal) activity to profile human CD8+ T-cell subsets from young and old donors. We stratified effector memory (CD8 EM ) and effector memory re-expressing CD45RA (CD8 EMRA ) subsets by the lowest (bottom 25%) and highest (top 25%) quartiles of SA-β-Gal signal. Results: CD8 EM and CD8 EMRA cells displayed the greatest within-subset heterogeneity in SA-β-Gal activity. The SA-β-Gal low and high populations occupied distinct regions in UMAP projections and were reproducibly enriched in different FlowSOM metaclusters, indicating that SA-β-Gal activity captures structured phenotypic states within differentiated CD8+ T-cell compartments. These states differed in senescence-associated markers, including CD27, CD28, CD57, and CX3CR1, as well as granzyme-associated programs involving Gzm A, B and K, whereas chronological age had only a limited effect once subsets were analyzed separately. Functionally, nutrient-limited conditions unmasked marked differences in cell death susceptibility between these populations. Following PMA/ionomycin stimulation, SA-β-Gal high CD8 EM and CD8 EMRA cells underwent accelerated stimulation-induced cell death, showed increased caspase-3/7 activation, and exhibited lower post-treatment γH2AX signal relative to SA-β-Gal low counterparts. In contrast, in the absence of stimulation-induced energetic demand, SA-β-Gal high cells displayed greater resistance to cell death. Discussion: Together, SA-β-Gal stratification resolves structured heterogeneity within human CD8 effector T cells and supports a context-dependent model in which senescence-associated effector states become selectively vulnerable to stimulation-induced death under metabolic stress.
- Open Access
- 1 January 2026
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 12 (1)
Lower CD8+ T‐cell senescence partially mediates the neuroprotection of higher aerobic fitness
INTRODUCTION: Immunosenescence – age‐related changes in immunity – may exacerbate the pathologic processes of Alzheimer's disease (AD), a condition that disproportionately affects African Americans. Fortunately, a higher level of aerobic fitness is linked to both reduced immunosenescence and lower AD risk. However, it remains unclear whether higher aerobic fitness and decreased AD is mediated by lower proportions of T‐cell senescence. In a cohort of older African Americans, we aimed to (1) examine the relationship between aerobic fitness and generalization (a cognitive indicator of AD risk) and (2) investigate whether T‐cell senescence mediated this relationship. METHODS: A total of 231 older African American participants from the Aging & Brain Health Alliance ( M age = 70.74 years, SD = 6.40; M education = 14.02 years, SD = 2.25; M MoCA = 23.16, SD = 2.63) responded to demographic, health, and lifestyle questionnaires; completed a cognitive battery including a generalization task (stimulus differentiation and transfer task); underwent anthropometric and physical performance measures; and provided a blood sample for T‐cell senescence characterization. Peripheral blood mononuclear cells were isolated and analyzed for senescence‐associated beta‐galactosidase activity as a measure of proportions of cytotoxic CD8+ T‐cell senescence. Aerobic fitness (VO 2 peak) was estimated from the six‐minute walk test. Covariates included age, sex, education, and waist‐to‐hip ratio. RESULTS: Higher aerobic fitness was significantly associated with fewer generalization errors. Furthermore, higher aerobic fitness was associated with lower CD8+ T‐cell senescence ( = −0.15, p = 0.02), which was associated with fewer generalization errors (= −0.17, p = 0.01). Overall, 15% of the effect of higher aerobic fitness on fewer generalization errors was mediated by lower CD8+ T‐cell senescence. DISCUSSION: One pathway by which higher aerobic fitness is associated with lower AD risk in older African Americans is through lower proportions of CD8+ T‐cell senescence. These results highlight the immune and cognitive function benefits of a physically active lifestyle, particularly in a demographic that faces a higher risk for AD.
- 1 January 2026
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 12 (1)
Open AccessLower CD8+ T‐cell senescence partially mediates the neuroprotection of higher aerobic fitness
INTRODUCTION: Immunosenescence – age‐related changes in immunity – may exacerbate the pathologic processes of Alzheimer's disease (AD), a condition that disproportionately affects African Americans. Fortunately, a higher level of aerobic fitness is linked to both reduced immunosenescence and lower AD risk. However, it remains unclear whether higher aerobic fitness and decreased AD is mediated by lower proportions of T‐cell senescence. In a cohort of older African Americans, we aimed to (1) examine the relationship between aerobic fitness and generalization (a cognitive indicator of AD risk) and (2) investigate whether T‐cell senescence mediated this relationship. METHODS: A total of 231 older African American participants from the Aging & Brain Health Alliance ( M age = 70.74 years, SD = 6.40; M education = 14.02 years, SD = 2.25; M MoCA = 23.16, SD = 2.63) responded to demographic, health, and lifestyle questionnaires; completed a cognitive battery including a generalization task (stimulus differentiation and transfer task); underwent anthropometric and physical performance measures; and provided a blood sample for T‐cell senescence characterization. Peripheral blood mononuclear cells were isolated and analyzed for senescence‐associated beta‐galactosidase activity as a measure of proportions of cytotoxic CD8+ T‐cell senescence. Aerobic fitness (VO 2 peak) was estimated from the six‐minute walk test. Covariates included age, sex, education, and waist‐to‐hip ratio. RESULTS: Higher aerobic fitness was significantly associated with fewer generalization errors. Furthermore, higher aerobic fitness was associated with lower CD8+ T‐cell senescence ( = −0.15, p = 0.02), which was associated with fewer generalization errors (= −0.17, p = 0.01). Overall, 15% of the effect of higher aerobic fitness on fewer generalization errors was mediated by lower CD8+ T‐cell senescence. DISCUSSION: One pathway by which higher aerobic fitness is associated with lower AD risk in older African Americans is through lower proportions of CD8+ T‐cell senescence. These results highlight the immune and cognitive function benefits of a physically active lifestyle, particularly in a demographic that faces a higher risk for AD.
- Open Access
- 31 December 2025
- Published by Elsevier in Cell Reports
- Vol. 45 (1) , 116795
Age-independent and targetable transcription factor networks regulating CD8+ T cell senescence in aging humans
- 31 December 2025
- Published by Elsevier in Cell Reports
- Vol. 45 (1) , 116795
Open AccessAge-independent and targetable transcription factor networks regulating CD8+ T cell senescence in aging humans
- Open Access
Senescent CD8+ T Effector Memory Cells are Functionally Impaired, Enriched in Aging and Disease, and a Barrier to Immunotherapy
Senescent cells play important roles in various biological processes that promote fitness and health, however, their timely elimination by immune cells is critical to maintain tissue homeostasis and prevent disease. Despite this, senescent cells progressively accumulate systemically with age, suggesting that certain immune cells also become senescent and dysfunctional during aging. Supporting this, we previously demonstrated that CD8 T cells, immune cells capable of targeting senescent cells, increasingly develop characteristics of senescence with advancing age in humans. Here, we further characterized the senescence state of human SA-βGal-expressing CD8 T effector cells, their functional capabilities, and their involvement in aging and disease. Single-cell RNA sequencing revealed that SA-βGal-expressing CD8 T cells with unique transcriptional signatures develop in all stages of T cell differentiation, including in effector memory (EM) T cells. SA-βGal-expressing CD8 TEM cells expressed various classical markers of senescence and were significantly impaired in their ability to proliferate, produce cytokines, and eliminate senescent human stromal cells, compared to CD8 TEM cells with low SA-βGal activity. Gene signatures of senescent SA-βGal-expressing CD8 TEM cells were enriched in CD8 T cells from older human donors, patients with age-related disorders, cancer, and smokers. Furthermore, our results demonstrate that T cell senescence is distinct from and dominant over T cell exhaustion, limiting the response of CD8 TEM cells to immunotherapy. Collectively, our study demonstrates that the senescence state impairs the functions of CD8 TEM cells and reveals the involvement of senescent and dysfunctional CD8 TEM cells in aging, disease, exposure to toxins, and responses to immunotherapy.
Open AccessSenescent CD8+ T Effector Memory Cells are Functionally Impaired, Enriched in Aging and Disease, and a Barrier to Immunotherapy
Senescent cells play important roles in various biological processes that promote fitness and health, however, their timely elimination by immune cells is critical to maintain tissue homeostasis and prevent disease. Despite this, senescent cells progressively accumulate systemically with age, suggesting that certain immune cells also become senescent and dysfunctional during aging. Supporting this, we previously demonstrated that CD8 T cells, immune cells capable of targeting senescent cells, increasingly develop characteristics of senescence with advancing age in humans. Here, we further characterized the senescence state of human SA-βGal-expressing CD8 T effector cells, their functional capabilities, and their involvement in aging and disease. Single-cell RNA sequencing revealed that SA-βGal-expressing CD8 T cells with unique transcriptional signatures develop in all stages of T cell differentiation, including in effector memory (EM) T cells. SA-βGal-expressing CD8 TEM cells expressed various classical markers of senescence and were significantly impaired in their ability to proliferate, produce cytokines, and eliminate senescent human stromal cells, compared to CD8 TEM cells with low SA-βGal activity. Gene signatures of senescent SA-βGal-expressing CD8 TEM cells were enriched in CD8 T cells from older human donors, patients with age-related disorders, cancer, and smokers. Furthermore, our results demonstrate that T cell senescence is distinct from and dominant over T cell exhaustion, limiting the response of CD8 TEM cells to immunotherapy. Collectively, our study demonstrates that the senescence state impairs the functions of CD8 TEM cells and reveals the involvement of senescent and dysfunctional CD8 TEM cells in aging, disease, exposure to toxins, and responses to immunotherapy.
- Open Access
- 9 December 2025
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24 (1)
The cellular senescence–metabolism axis: emerging insights into T cell dynamics in the context of biological aging
The exponential growth of immunometabolism-related studies in the last 10 years has made it very clear that metabolism is a key player in the effe
- 9 December 2025
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24 (1)
Open AccessThe cellular senescence–metabolism axis: emerging insights into T cell dynamics in the context of biological aging
The exponential growth of immunometabolism-related studies in the last 10 years has made it very clear that metabolism is a key player in the effe
- Open Access
Epigenetic mechanisms regulating CD8+ T cell senescence in aging humans
Aging leads to the decline of immunity, rendering the elderly susceptible to infection and disease. In the CD8+ T cell compartment, aging leads to a substantial increase of cells with high levels of senescence-associated ß-galactosidase activity (SA-ßGal) and other senescence characteristics, including a pro-inflammatory transcriptome and impaired proliferative potential. Using senescent cell isolation coupled with multiomic profiling, here we characterized the epigenetic mechanisms regulating CD8+ T cell senescence in a cohort of younger and older donors. High levels of SA-ßGal activity defined changes to global transcriptomes and chromatin accessibility landscapes, with a minor effect of age. Widespread enhancer remodeling was required for the repression of functional CD8+ T cell genes and upregulation of inflammatory and secretory pathway genes. Mechanistically, the senescence program in CD8+ T cells was controlled by chromatin state-specific transcription factor (TF) networks whose composition was largely insensitive to donor age. Pharmacological inhibition of TF network nodes AP1, KLF5, and RUNX2 modulated the transcriptional output, demonstrating the feasibility of TF network perturbation as an approach to modulate CD8+ T cell senescence. Further, CD8+ T cell senescence gene signatures faithfully predicted refractoriness to chimeric antigen receptor (CAR) T-cell therapy in a cohort of diffuse large B cell lymphomas and were highly enriched in the transcriptomes of peripheral CD8+ T cells of individuals with active systemic lupus erythematosus. Collectively, our findings demonstrate the potential of multiomic profiling in identifying key regulators of senescence across cell types and suggest a critical role of senescent CD8+ T cells in disease progression.
Open AccessEpigenetic mechanisms regulating CD8+ T cell senescence in aging humans
Aging leads to the decline of immunity, rendering the elderly susceptible to infection and disease. In the CD8+ T cell compartment, aging leads to a substantial increase of cells with high levels of senescence-associated ß-galactosidase activity (SA-ßGal) and other senescence characteristics, including a pro-inflammatory transcriptome and impaired proliferative potential. Using senescent cell isolation coupled with multiomic profiling, here we characterized the epigenetic mechanisms regulating CD8+ T cell senescence in a cohort of younger and older donors. High levels of SA-ßGal activity defined changes to global transcriptomes and chromatin accessibility landscapes, with a minor effect of age. Widespread enhancer remodeling was required for the repression of functional CD8+ T cell genes and upregulation of inflammatory and secretory pathway genes. Mechanistically, the senescence program in CD8+ T cells was controlled by chromatin state-specific transcription factor (TF) networks whose composition was largely insensitive to donor age. Pharmacological inhibition of TF network nodes AP1, KLF5, and RUNX2 modulated the transcriptional output, demonstrating the feasibility of TF network perturbation as an approach to modulate CD8+ T cell senescence. Further, CD8+ T cell senescence gene signatures faithfully predicted refractoriness to chimeric antigen receptor (CAR) T-cell therapy in a cohort of diffuse large B cell lymphomas and were highly enriched in the transcriptomes of peripheral CD8+ T cells of individuals with active systemic lupus erythematosus. Collectively, our findings demonstrate the potential of multiomic profiling in identifying key regulators of senescence across cell types and suggest a critical role of senescent CD8+ T cells in disease progression.
- 12 July 2024
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 213 (5) , 577-587
TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells
TLRs are the most thoroughly studied group of pattern-recognition receptors that play a central role in innate immunity. Among them, TLR10 (CD290) remains the only TLR family member without a known ligand and clearly defined functions. One major impediment to studying TLR10 is its absence in mice. A recent study on TLR10 knock-in mice demonstrated its intrinsic inhibitory role in B cells, indicating that TLR10 is a potential drug target in autoimmune diseases. In this study, we interrogated the expression and function of TLR10 in human plasmacytoid dendritic cells (pDCs). We have seen that primary human pDCs, B cells, and monocytes constitutively express TLR10. Upon preincubation with an anti-TLR10 Ab, production of cytokines in pDCs was downregulated in response to stimulation with DNA and RNA viruses. Upon further investigation into the possible mechanism, we documented phosphorylation of STAT3 upon Ab-mediated engagement of TLR10. This leads to the induction of inhibitory molecule suppressor of cytokine signaling 3 (SOCS3) expression. We have also documented the inhibition of nuclear translocation of transcription factor IFN regulatory factor 7 (IRF7) in pDCs following TLR10 engagement. Our data provide the (to our knowledge) first evidence that TLR10 is constitutively expressed on the surface of human pDCs and works as a regulator of their innate response. Our findings indicate the potential of harnessing the function of pDCs by Ab-mediated targeting of TLR10 that may open a new therapeutic avenue for autoimmune disorders.
- 12 July 2024
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 213 (5) , 577-587
TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells
TLRs are the most thoroughly studied group of pattern-recognition receptors that play a central role in innate immunity. Among them, TLR10 (CD290) remains the only TLR family member without a known ligand and clearly defined functions. One major impediment to studying TLR10 is its absence in mice. A recent study on TLR10 knock-in mice demonstrated its intrinsic inhibitory role in B cells, indicating that TLR10 is a potential drug target in autoimmune diseases. In this study, we interrogated the expression and function of TLR10 in human plasmacytoid dendritic cells (pDCs). We have seen that primary human pDCs, B cells, and monocytes constitutively express TLR10. Upon preincubation with an anti-TLR10 Ab, production of cytokines in pDCs was downregulated in response to stimulation with DNA and RNA viruses. Upon further investigation into the possible mechanism, we documented phosphorylation of STAT3 upon Ab-mediated engagement of TLR10. This leads to the induction of inhibitory molecule suppressor of cytokine signaling 3 (SOCS3) expression. We have also documented the inhibition of nuclear translocation of transcription factor IFN regulatory factor 7 (IRF7) in pDCs following TLR10 engagement. Our data provide the (to our knowledge) first evidence that TLR10 is constitutively expressed on the surface of human pDCs and works as a regulator of their innate response. Our findings indicate the potential of harnessing the function of pDCs by Ab-mediated targeting of TLR10 that may open a new therapeutic avenue for autoimmune disorders.
- Open Access
- 25 October 2023
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 2 (11)
Interferon ɛ restricts Zika virus infection in the female reproductive tract
Interferon ε (IFNε) is a unique type I IFN that has been implicated in host defense against sexually transmitted infections (STIs). Zika virus (ZIKV), an emerging pathogen, can infect the female reproductive tract (FRT) and cause devastating diseases, particularly in pregnant women. How IFNε contributes to protection against ZIKV infection in vivo is unknown. Here, we show that IFNε plays a critical role in host protection against vaginal ZIKV infection in mice. We found that IFNε was expressed not only by epithelial cells in the FRT, but also by immune and stromal cells at baseline or after exposure to viruses or specific TLR agonists. IFNε-deficient mice exhibited abnormalities in the epithelial border and underlying tissue in the cervicovaginal tract, and these defects were associated with increased susceptibility to vaginal, but not subcutaneous ZIKV infection. IFNε-deficiency resulted in an increase in magnitude, duration, and depth of ZIKV infection in the FRT. Critically, intravaginal administration of recombinant IFNε protected Ifnε-/- mice and highly susceptible Ifnar1-/- mice against vaginal ZIKV infection, indicating that IFNε was sufficient to provide protection even in the absence of signals from other type I IFNs and in an IFNAR1-independent manner. Our findings reveal a potentially critical role for IFNε in mediating protection against transmission of ZIKV in the context of sexual contact.
- 25 October 2023
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 2 (11)
Open AccessInterferon ɛ restricts Zika virus infection in the female reproductive tract
Interferon ε (IFNε) is a unique type I IFN that has been implicated in host defense against sexually transmitted infections (STIs). Zika virus (ZIKV), an emerging pathogen, can infect the female reproductive tract (FRT) and cause devastating diseases, particularly in pregnant women. How IFNε contributes to protection against ZIKV infection in vivo is unknown. Here, we show that IFNε plays a critical role in host protection against vaginal ZIKV infection in mice. We found that IFNε was expressed not only by epithelial cells in the FRT, but also by immune and stromal cells at baseline or after exposure to viruses or specific TLR agonists. IFNε-deficient mice exhibited abnormalities in the epithelial border and underlying tissue in the cervicovaginal tract, and these defects were associated with increased susceptibility to vaginal, but not subcutaneous ZIKV infection. IFNε-deficiency resulted in an increase in magnitude, duration, and depth of ZIKV infection in the FRT. Critically, intravaginal administration of recombinant IFNε protected Ifnε-/- mice and highly susceptible Ifnar1-/- mice against vaginal ZIKV infection, indicating that IFNε was sufficient to provide protection even in the absence of signals from other type I IFNs and in an IFNAR1-independent manner. Our findings reveal a potentially critical role for IFNε in mediating protection against transmission of ZIKV in the context of sexual contact.
- 8 February 2023
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 113 (4) , 349-350
Postacute SARS-CoV-2 (PASC): a complicated syndrome that is long on unanswered questions
Patricia Fitzgerald-Bocarsly, PhD; Post-acute SARS-CoV-2 (PASC): A complicated syndrome that is long on unanswered questions, Journal of Leukocyte Biology, , qi
- 8 February 2023
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 113 (4) , 349-350
Postacute SARS-CoV-2 (PASC): a complicated syndrome that is long on unanswered questions
Patricia Fitzgerald-Bocarsly, PhD; Post-acute SARS-CoV-2 (PASC): A complicated syndrome that is long on unanswered questions, Journal of Leukocyte Biology, , qi